ALZ-801 Works Against Alzheimer’s by Preventing Protein Component Clumping, Study Reports

ALZ-801 Works Against Alzheimer’s by Preventing Protein Component Clumping, Study Reports
The Alzheimer’s therapy ALZ-801 works by preventing protein components from clumping together to trigger the amyloid plaque accumulation in the brain that causes the disease, researchers say. Disease-modifying drugs for Alzheimer’s and other neurodegenerative diseases could evolve from the findings, the team said. Researchers knew that tramiprosate, the active ingredient in Alzheon‘s ALZ-801, inhibited the beta amyloid protein that

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

3 comments

  1. Jack Beatrice says:

    Would like to participate in the clical trails for ALZ-801. My wife is 66 and was diagnosed two years ago.

    • Tim Bossie says:

      Jack, please talk with your doctor about the possibility of participating in this trial and if it is in your area.

  2. Dante J Marciani says:

    Very exciting work. The MOA of this small compound suggests the possibility of a multi-prong approach to deal with amyloid toxicity. Inhibiting the formation of toxic oligomers with ALZ-801, and using specific antibodies to neutralize the toxicity of those oligomers already present.

Leave a Comment

Your email address will not be published. Required fields are marked *